BDNF and epilepsy: A large set of diametric psychopharmacological patterns emerged from the analyses, with regard to the pathways involving BDNF, PI3K, the NMDA and mGlur5 receptors, kynurenine, agmatine, the endocannabinoid anandamide, epilepsy and electroconvulsive therapy.